Ca-independent phospholipase A (GVIA iPLA) has gained increasing interest recently as it has been recognized as a participant in biological processes underlying diabetes development and autoimmune-based neurological disorders. The development of potent GVIA iPLA inhibitors is of great importance because only a few have been reported so far. We present a novel class of GVIA iPLA inhibitors based on the β-lactone ring.
View Article and Find Full Text PDFIn the quest for new antibacterial agents, a series of novel long- and medium-chain mono- and disubstituted β-lactones was developed. Their activity against three pathogenic mycobacteria-M. abscessus, M.
View Article and Find Full Text PDF